GBA1 and depressive symptom measurement: Although not significant after p value adjustment, we found a similar trend and noticed that motor symptoms such as gait disorder, non-motor symptoms such as depression and hallucinations, were associated with a more aggressive clinical phenotype in severe GBA1 carriers, supporting the effect of differential GBA1 variant severity20,32.